Insulin Degludec: A Significant Advancement in Ultralong-Acting Basal Insulin.
- Published in:
- 2013
- By:
- Publication type:
- Editorial
Works matching IS 18696953 AND DT 2013 AND VI 4 AND IP 2
Results: 23
1
2
Vildagliptin is Effective for Glycemic Control in Diabetic Patients Undergoing either Hemodialysis or Peritoneal Dialysis.
- Published in:
- Diabetes Therapy, 2013, v. 4, n. 2, p. 321, doi. 10.1007/s13300-013-0029-8
- By:
- Publication type:
- Article
3
Management of Type 2 Diabetes Mellitus in Older Patients: Current and Emerging Treatment Options.
- Published in:
- Diabetes Therapy, 2013, v. 4, n. 2, p. 239, doi. 10.1007/s13300-013-0039-6
- By:
- Publication type:
- Article
4
Effects of Switching from Insulin Glargine or Detemir to Insulin Degludec in Patients with Type 1 Diabetes Mellitus.
- Published in:
- Diabetes Therapy, 2013, v. 4, n. 2, p. 461, doi. 10.1007/s13300-013-0048-5
- By:
- Publication type:
- Article
5
Safety and Effectiveness of Switching from a Basal-only to Biphasic Insulin Aspart 30 Insulin Regimen.
- Published in:
- Diabetes Therapy, 2013, v. 4, n. 2, p. 309, doi. 10.1007/s13300-013-0032-0
- By:
- Publication type:
- Article
6
Adherence to Therapies in Patients with Type 2 Diabetes.
- Published in:
- Diabetes Therapy, 2013, v. 4, n. 2, p. 175, doi. 10.1007/s13300-013-0034-y
- By:
- Publication type:
- Article
7
Physician Preferences for Extra-Glycemic Effects of Type 2 Diabetes Treatments.
- Published in:
- Diabetes Therapy, 2013, v. 4, n. 2, p. 443, doi. 10.1007/s13300-013-0046-7
- By:
- Publication type:
- Article
8
Experience with Vildagliptin in Patients ≥75 Years with Type 2 Diabetes and Moderate or Severe Renal Impairment.
- Published in:
- Diabetes Therapy, 2013, v. 4, n. 2, p. 257, doi. 10.1007/s13300-013-0027-x
- By:
- Publication type:
- Article
9
Incretin Therapy for Type 2 Diabetes in Spain: A Cost-Effectiveness Analysis of Liraglutide Versus Sitagliptin.
- Published in:
- Diabetes Therapy, 2013, v. 4, n. 2, p. 417, doi. 10.1007/s13300-013-0044-9
- By:
- Publication type:
- Article
10
Efficacy of Initial Basal-Supported Oral Therapy with Sitagliptin in Untreated Type 2 Diabetes.
- Published in:
- Diabetes Therapy, 2013, v. 4, n. 2, p. 409, doi. 10.1007/s13300-013-0043-x
- By:
- Publication type:
- Article
11
Incretin-Based Therapies: Focus on Effects Beyond Glycemic Control Alone.
- Published in:
- Diabetes Therapy, 2013, v. 4, n. 2, p. 221, doi. 10.1007/s13300-013-0040-0
- By:
- Publication type:
- Article
12
Clinical Experience with Insulin Detemir in Patients with Type 2 Diabetes from the Near East Countries.
- Published in:
- Diabetes Therapy, 2013, v. 4, n. 2, p. 399, doi. 10.1007/s13300-013-0041-z
- By:
- Publication type:
- Article
13
Safety and Effectiveness of Biphasic Insulin Aspart 30 in Different Age-Groups: Achieve Sub-Analysis.
- Published in:
- Diabetes Therapy, 2013, v. 4, n. 2, p. 347, doi. 10.1007/s13300-013-0033-z
- By:
- Publication type:
- Article
14
Age-Specific Effectiveness and Safety of Newly Initiated Insulin Therapy in Japanese Patients with Uncontrolled Diabetes.
- Published in:
- Diabetes Therapy, 2013, v. 4, n. 2, p. 473, doi. 10.1007/s13300-013-0049-4
- By:
- Publication type:
- Article
15
Experience with Vildagliptin in Type 2 Diabetic Patients Fasting During Ramadan in France: Insights from the VERDI Study.
- Published in:
- Diabetes Therapy, 2013, v. 4, n. 2, p. 385, doi. 10.1007/s13300-013-0038-7
- By:
- Publication type:
- Article
16
Using Exenatide Twice Daily or Insulin in Clinical Practice: Results from CHOICE.
- Published in:
- Diabetes Therapy, 2013, v. 4, n. 2, p. 285, doi. 10.1007/s13300-013-0037-8
- By:
- Publication type:
- Article
17
Adding Saxagliptin to Metformin Extended Release (XR) or Uptitration of Metformin XR: Efficacy on Daily Glucose Measures.
- Published in:
- Diabetes Therapy, 2013, v. 4, n. 2, p. 269, doi. 10.1007/s13300-013-0028-9
- By:
- Publication type:
- Article
18
Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Multiple Rising Doses of Empagliflozin in Patients with Type 2 Diabetes Mellitus.
- Published in:
- Diabetes Therapy, 2013, v. 4, n. 2, p. 331, doi. 10.1007/s13300-013-0030-2
- By:
- Publication type:
- Article
19
Erratum to: Safety and Tolerability of Sitagliptin in Type 2 Diabetes: Pooled Analysis of 25 Clinical Studies.
- Published in:
- 2013
- By:
- Publication type:
- Correction Notice
20
Initial Management of Severe Hyperglycemia in Patients with Type 2 Diabetes: an Observational Study.
- Published in:
- Diabetes Therapy, 2013, v. 4, n. 2, p. 375, doi. 10.1007/s13300-013-0036-9
- By:
- Publication type:
- Article
21
Annual Medical Costs of Swedish Patients with Type 2 Diabetes Before and After Insulin Initiation.
- Published in:
- Diabetes Therapy, 2013, v. 4, n. 2, p. 363, doi. 10.1007/s13300-013-0035-x
- By:
- Publication type:
- Article
22
Sodium Glucose Co-transporter Type 2 (SGLT2) Inhibitors: Targeting the Kidney to Improve Glycemic Control in Diabetes Mellitus.
- Published in:
- Diabetes Therapy, 2013, v. 4, n. 2, p. 195, doi. 10.1007/s13300-013-0042-y
- By:
- Publication type:
- Article
23
Dipeptidyl Peptidase-4 Inhibition in Patients with Type 2 Diabetes Treated with Saxagliptin, Sitagliptin, or Vildagliptin.
- Published in:
- Diabetes Therapy, 2013, v. 4, n. 2, p. 431, doi. 10.1007/s13300-013-0045-8
- By:
- Publication type:
- Article